Related Experiment Videos
Diagnosis and treatment of diffuse ileojejunitis.
The American Journal of Gastroenterology
|November 1, 1977
Summary
Diffuse ileojejunitis, resembling Crohn's disease, was diagnosed and treated in thirteen patients. Most patients responded well to anti-inflammatory drugs, with surgery needed in only four cases.
Area of Science:
- Gastroenterology
- Internal Medicine
- Inflammatory Bowel Disease
Background:
- Diffuse ileojejunitis is a rare gastrointestinal condition.
- Its relationship to other inflammatory bowel diseases, such as Crohn's disease, requires further investigation.
- Distinguishing it from celiac sprue is important for accurate diagnosis and treatment.
Purpose of the Study:
- To describe the clinical characteristics, treatment, and outcomes of patients with diffuse ileojejunitis.
- To evaluate the efficacy of anti-inflammatory drugs and surgical interventions.
- To explore the potential relationship between diffuse ileojejunitis and Crohn's disease.
Main Methods:
- Retrospective analysis of thirteen patients diagnosed with diffuse ileojejunitis over ten years.
- Review of patient records, including diagnostic methods, treatment regimens, and clinical outcomes.
- Assessment of therapeutic responses to sulfasalazine, steroids, and surgical resection.
Main Results:
- Thirteen patients were diagnosed and treated for diffuse ileojejunitis.
- The condition showed significant clinical resemblance to Crohn's disease.
- No clear association with celiac sprue was identified.
- The majority of patients achieved therapeutic success with non-surgical management, primarily using sulfasalazine and steroids.
- Four patients required resectional surgery.
- No mortality was observed in the patient cohort.
Conclusions:
- Diffuse ileojejunitis may represent a variant of Crohn's disease.
- Anti-inflammatory drugs like sulfasalazine and steroids are effective in managing the condition.
- Non-surgical management is successful for most patients, with surgery reserved for specific cases.
- Diffuse ileojejunitis can be managed effectively with a low mortality rate.